CommercialCoverageMedium impact
Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry (2.02.08)
Blue Shield of California·CA · Cardiology, Internal Medicine·Medical Policy
Effective date
Aug 1, 2026
We identified it
Jul 31, 2026
Summary
Blue Shield of California updated its policy on ambulatory event monitors and mobile cardiac outpatient telemetry, effective August 1, 2026. The policy clarifies medical necessity criteria for external ambulatory event monitors, implantable monitors, and cardiac telemetry for specific cardiac conditions including infrequent arrhythmia symptoms, post-ablation atrial fibrillation monitoring, and cryptogenic stroke evaluation. Certain uses (asymptomatic monitoring, medication effectiveness tracking, and ischemia detection) remain investigational and non-covered.
Action Required
By August 1, 2026: Billing team must review and update prior authorization protocols for ambulatory cardiac monitoring claims. Providers should document specific medical necessity criteria from the policy (infrequent symptoms <48 hours, post-ablation AF status, or cryptogenic stroke with negative workup) in patient records before submitting claims. Ensure that claims for asymptomatic monitoring, medication effectiveness evaluation, or ST-segment ischemia detection are flagged as investigational and denied per policy Section IV. Update clinical documentation templates to capture required elements: symptom frequency, prior diagnostic test results (Holter monitor status), and real-time monitoring justification for telemetry requests. Coordinate with cardiology providers to align ordering practices with the narrower medical necessity definitions. Failure to align billing practices may result in claim denials for services that no longer meet coverage criteria.